EMJ GOLD - European Medical Journal

This site is intended for healthcare professionals

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
Cartoon brain on green background

New drug could offer another way to treat stroke

Currently in phase 2 trials, BB-031 is the first new mechanistic approach to ischemic stroke treatment in nearly 30 years.
Pill on purple background

Paracetamol safety: New study finds no autism link

A review has provided evidence debunking claims that acetaminophen (paracetamol) use during pregnancy increases the risk of ASDand ADHD.
vaccine

FDA orders seizure warnings for major flu vaccines

The FDA has directed pharma companies of influenza vaccines to update their product labelling to include the risk of fever-induced seizures.
Person looking into distance with telescope at arrow pointing upwards

UK clinical trial applications on the rise, finds MHRA

The 9% growth in 2025 could signal that the country is on track to become a more attractive destination for pharamceutical R&D.
Month in pharma news, explained

Month in pharma news, explained - December 2025

In this monthly news roundup, we take a look back at top moments from the pharmaceutical industry. It’s time to reflect on December 2025.
Handshake

Lilly and NVIDIA: a $1bn leap for drug discovery

Eli Lilly and NVIDIA have unveiled a first-of-its-kind AI co-innovation lab, aiming to solving the most complex bottlenecks in pharma.
desktop showing data

Pharma to FDA: upgrade cell and gene data sharing

The pharmaceutical industry is calling on the FDA to modernise how it tracks the long-term safety and efficacy of cell and gene therapies.
Two people making a handshake

J&J acquires Halda to take on cancer cell resistance

J&J successfully acquired Halda Therapeutics for $3.05bn integrating Halda’s RIPTAC platform into J&J’s oncology portfolio.
We’ve noticed you’re accessing
from North/South America.